Evidence map›Paper›PMID 30728405›Full record

Observational studyScientific reports2019

Differential expression of CXCR3 and CCR6 on CD4

Paulo S Silveira-Mattos, Gopalan Narendran, Kevan Akrami, Kiyoshi F Fukutani, Selvaraj Anbalagan, Kaustuv Nayak, Sudha Subramanyam, Rajasekaran Subramani, Caian L Vinhaes, Deivide Oliveira-de Souza and 7 more

Erratum issuedOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. [Characterization of immune reconstitution inflammatory syndrome in a Mexican cohort].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Observational
  2. Chikungunya virus-specific CD4Cell reports. Medicine · 2025
    Article
  3. Article
  4. CD4bioRxiv : the preprint server for biology · 2023
    Article
  5. Article
  6. Review
  7. Phenotypic Profile ofOpen forum infectious diseases · 2023
    Article
  8. Article
  9. Article
  10. Frequency of CXCR3Frontiers in immunology · 2022
    Article
  11. Article
  12. American journal of respiratory cell and molecular biology · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Paulo S Silveira-MattosInstituto Gonçalo Moniz, Salvador, Bahia, Brazil.
Gopalan NarendranNational Institute for Research in Tuberculosis, Chennai, India.ORCID 0000-0002-8049-7541
Kevan AkramiInstituto Gonçalo Moniz, Salvador, Bahia, Brazil.
Kiyoshi F FukutaniInstituto Gonçalo Moniz, Salvador, Bahia, Brazil.ORCID 0000-0003-2223-0918
Selvaraj AnbalaganNational Institute for Research in Tuberculosis, Chennai, India.
Kaustuv NayakNational Institute for Research in Tuberculosis, Chennai, India.
Sudha SubramanyamNational Institute for Research in Tuberculosis, Chennai, India.
Rajasekaran SubramaniNational Institute for Research in Tuberculosis, Chennai, India.
Caian L VinhaesInstituto Gonçalo Moniz, Salvador, Bahia, Brazil.
Deivide Oliveira-de SouzaInstituto Gonçalo Moniz, Salvador, Bahia, Brazil.
Lis R AntonelliLaboratório de Biologia e Imunologia de Doenças Infecciosas e Parasitárias, Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.
Kumar SatagopanGovernment Hospital of Thoracic Medicine, Tambaram, Chennai, India.
Brian O PorterClinical HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Alan SherImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Soumya SwaminathanNational Institute for Research in Tuberculosis, Chennai, India.
Irini SeretiClinical HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Bruno B AndradeInstituto Gonçalo Moniz, Salvador, Bahia, Brazil. bruno.andrade@fiocruz.br.ORCID 0000-0001-6833-3811
National Institute of Research in Tuberculosis · INNational Institutes of Health · USFundação de Amparo à Pesquisa do Estado da Bahia · BRFundação Oswaldo Cruz · BRGovernment Hospital of Thoracic Medicine · INUniversity of California San Diego · US

Funding

Inflammatory determinants of disease severity and treatment outcome in TB patientsU01AI115940 · NIAID · UNIVERSITY OF CAPE TOWN · PI SHER, ALAN, WILKINSON, ROBERT JOHN · 2015 to 2019
$1.1M
NIAID NIH HHS U01 AI115940
6 · The paper itself

Abstract

Immune reconstitution inflammatory syndrome (IRIS) occurs in up to 40% of individuals co-infected with pulmonary tuberculosis (PTB) and HIV, primarily upon antiretroviral therapy (ART) initiation. Phenotypic changes in T-cells during TB-IRIS and their relationship with systemic inflammation are not fully understood. In this prospective cohort study, we followed 48 HIV-positive patients with PTB from South India before and after ART initiation, examining T-lymphocyte subsets and inflammatory biomarkers in peripheral blood. Quantification of naïve (CD27

Indexed as

AdultAgedAnti-Retroviral AgentsCD4-Positive T-LymphocytesCohort StudiesCoinfectionFemaleHIV InfectionsHumansImmune Reconstitution Inflammatory SyndromeImmunologic MemoryMaleMiddle AgedProspective StudiesRandomized Controlled Trials as TopicReceptors, CCR6Anti-Retroviral AgentsCCR6 protein, humanCXCR3 protein, humanReceptors, CCR6Receptors, CXCR3

Identifiers

PMID30728405
PMCPMC6365576
OpenAlexW2914063951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.